Short Sellers Grow More Selective on Major Pharma Stocks
The September 14 short interest data have been compared with the previous figures, and short interest moves in these selected pharmaceutical stocks were mixed.
The September 14 short interest data have been compared with the previous figures, and short interest moves in these selected pharmaceutical stocks were mixed.
Teva Pharmaceuticals shares made a solid gain on Monday morning after the company announced a critical approval by the FDA.
The August 31 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks decreased.
Here 24/7 Wall St. has included a calendar of some of the biggest companies expecting clinical trial and U.S. Food and Drug Administration (FDA) updates in September.
The top analyst upgrades, downgrades and initiations seen on Friday include Apple, Caterpillar, Costco, GW Pharmaceuticals, NXP Semiconductors, Southwest Airlines, Teva Pharmaceutical, Ulta Beauty and Wells Fargo.
The August 15 short interest data have been compared with the previous figures, and short interest in these selected pharmaceutical stocks was mixed.
The FDA is extending the expiration dates for certain EpiPens in light of the national shortage ahead of the back-to-school season.
Mylan has had a stranglehold on the market for EpiPen, but this is all changing after the FDA approved Teva for a generic version of it.
Teva and Regeneron both saw handy gains on Thursday after the companies posted positive topline results from their late-stage trial of fasinumab in patients with chronic pain from osteoarthritis (OA) of the…
The July 31 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks increased.
The top analyst upgrades, downgrades and other research calls from Friday include Blue Apron, Energy Transfer Partners, Funko, Symantec, Tesla, Teva Pharmaceutical and TripAdvisor.
Teva shares stumbled after it released its most recent quarterly results before the markets opened on Thursday.
The July 13 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks decreased.
The June 29 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks decreased.
The June 15 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks increased.